Given the presence of more numerous macrophages upon Ang‐2 expression in intracerebral tumors and the importance of Ang‐2 for vessel growth, we hypothesized that targeting the angiopoietin/Tie2 system may be beneficial for GBM patients. This evidence concerns the gene TEK and glioblastoma.